Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10010411.6Aexternal-prioritypatent/EP2301524B1/en
Application filed by Gilead Sciences, Inc.filedCriticalGilead Sciences, Inc.
Publication of CY1114144T1publicationCriticalpatent/CY1114144T1/en
Μέθοδος και σύνθεση για τη θεραπεία πνευμονικών βακτηριακών λοιμώξεων που προκαλούνται από gram αρνητικά βακτήρια, κατάλληλη για τη θεραπεία λοιμώξεων που προκαλούνται από Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenza, Proteus mirabilis, είδη Enterobacter, Serratia marcescens, καθώς και εκείνων που προκαλούνται από Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans και ανθεκτική σε πολλά φάρμακα Pseudomonas aeruginosa, με χρήση συμπυκνωμένης τυποποίησης αζτρεονάμης ή φαρμακευτικώς αποδεκτού άλατος της, η οποία χορηγείται ως τυποποίηση αερολύματος ή ξηράς σκόνης.Method and composition for the treatment of pulmonary bacterial infections caused by gram negative bacteria, suitable for the treatment of infections caused by Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Haemophilus influenza, Haemophilus influenza those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans and many drug-resistant Pseudomonas aeruginosa, using a concentrated formulation of aztreonam or a pharmaceutically acceptable salt thereof, which is administered as a formulation.
CY20131100596T2000-12-272013-07-15
INHALATED AZRONEONAM FOR THE TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS
CY1114144T1
(en)
USE OF SIMPLE OR CONJUGATED DEXTRANS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO PREVENT OR REDUCE THE RISK OF INFECTION OF BACTERIAL PATHOGENIC GERMS.
Pharmaceutical combination, methods of treating or preventing diabetes and treating insulin resistance syndrome, parts kit, combined product and method of production thereof